• Analysts’ Top Healthcare Picks: Evolus (EOLS), Annovis Bio (ANVS) The Globe and Mail Thu, 09 Jul 2026 19:46:58 GMT
• Evolus Lands Licensing Rights for Profhilo Orange County Business Journal Wed, 08 Jul 2026 16:27:18 GMT
• Evolus, IBSA Partner to Develop and Commercialize Skin Quality Filler in the US The Dermatology Digest Wed, 08 Jul 2026 15:32:58 GMT
• Evolus signs licensing deal for Profhilo skin injectable in US Investing.com Wed, 08 Jul 2026 14:02:35 GMT
• Evolus Secures Exclusive U.S. Profhilo License From IBSA; No Upfronts, 15-Year Term TradingView Wed, 08 Jul 2026 13:13:01 GMT
• Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its I... Yahoo! Finance Canada Wed, 08 Jul 2026 13:00:00 GMT
• (EOLS) and the Role of Price-Sensitive Allocations Stock Traders Daily Tue, 07 Jul 2026 03:16:02 GMT
• price to sales forward of evolus, inc. common stock – nasdaq:eols TradingView Fri, 26 Jun 2026 08:42:56 GMT
• Enterprise value to EBITDA forward of Evolus, Inc. Common Stock – NASDAQ:EOLS TradingView Fri, 26 Jun 2026 08:39:48 GMT
• evolus inc (eols) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• evolus, inc.(nasdaqgm: eols) added to s&p pharmaceuticals select industry index marketscreener.com Mon, 22 Jun 2026 01:27:39 GMT
• Evolus, Inc.(NasdaqGM: EOLS) added to S&P Pharmaceuticals Select Industry Index marketscreener.com Sun, 21 Jun 2026 07:00:00 GMT
• is evolus (eols) finally turning the corner on profitability Kavout | AI Sun, 21 Jun 2026 01:03:01 GMT
• evolus inc (eols) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 11:22:36 GMT
• Evolus Inc (EOLS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 11:22:11 GMT
• Evolus Inc (EOLS) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Wed, 17 Jun 2026 22:47:07 GMT
• evolus inc (eols) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 21:30:48 GMT
• evolus inc (eols) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 21:26:08 GMT
• evolus inc (eols) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 21:23:18 GMT
• evolus inc (eols) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 21:23:16 GMT
• evolus inc (eols) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 20:59:46 GMT
• eols reiterated by btig -- price target maintained at $13.00 GuruFocus Wed, 17 Jun 2026 11:05:48 GMT
• btig maintains evolus(eols.us) with buy rating, maintains target price $13 Moomoo Wed, 17 Jun 2026 07:00:00 GMT
• evolus inc (eols) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• evolus inc (eols) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• evolus inc (eols) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• evolus inc (eols) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• understanding the setup: (eols) and scalable risk Stock Traders Daily Mon, 15 Jun 2026 00:56:02 GMT
• evolus shareholders re-elect directors and approve executive compensation Investing.com Sat, 13 Jun 2026 01:22:09 GMT
• evolus (eols) shareholders approve directors, auditor and say-on-pay at 2026 meeting Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• evolus shareholders re-elect directors and approve executive compensation Investing.com Fri, 12 Jun 2026 07:00:00 GMT
• mizuho securities maintains evolus(eols.us) with buy rating, maintains target price $15 Moomoo Mon, 08 Jun 2026 07:00:00 GMT
• cosmetic medicine awards will celebrate companies transforming the patient experience, launch hears Belfast Telegraph Sun, 07 Jun 2026 07:00:00 GMT
• evolus (nasdaq: eols) registers $250m shelf; $195.5m unsold re‑registered Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• eols: virtual meeting with management scheduled on june 11 GuruFocus Fri, 05 Jun 2026 01:06:24 GMT
• Evolus (EOLS) Jefferies Global Healthcare Conference 2026 Summary Quartr Thu, 04 Jun 2026 18:18:35 GMT
• eols: virtual meeting with management scheduled on june 11 GuruFocus Thu, 04 Jun 2026 07:00:00 GMT
• the technical signals behind (eols) that institutions follow Stock Traders Daily Wed, 03 Jun 2026 23:26:02 GMT
• earnings call transcript: evolus inc q1 2026 misses eps forecast, stock rises Investing.com Nigeria Thu, 28 May 2026 13:31:00 GMT
• evolus inc. (eols) q1 2026 earnings: eps surprises to the upside amid stock decline - trough earnings signal newsline.com Sun, 24 May 2026 07:00:00 GMT
• precision trading with evolus inc. (eols) risk zones Stock Traders Daily Sat, 23 May 2026 07:00:00 GMT
• Evolus to Participate in The Jefferies Global Healthcare Conference Business Wire Tue, 19 May 2026 07:00:00 GMT
• earnings call transcript: evolus inc q1 2026 misses eps forecast, stock rises Investing.com Nigeria Sat, 16 May 2026 08:16:49 GMT
• Evolus To Roll Out Estyme Injectable Hyaluronic Acid Fillers in Europe The Dermatology Digest Sat, 16 May 2026 07:00:00 GMT
• a quick look at today's ratings for evolus(eols.us), with a forecast between $13 to $17 富途牛牛 Fri, 15 May 2026 17:49:07 GMT
• earnings call transcript: evolus inc q1 2026 misses eps forecast, stock rises Investing.com Nigeria Fri, 15 May 2026 12:02:53 GMT
• evolus completes key nuceiva safety study, easing risk for aesthetic toxin investors TipRanks Thu, 14 May 2026 16:37:57 GMT
• evolus to roll out estyme injectable hyaluronic acid fillers in europe The Dermatology Digest Tue, 12 May 2026 14:25:36 GMT
• evolus, inc. launches estyme injectable hyaluronic acid gels collection in europe marketscreener.com Mon, 11 May 2026 15:51:22 GMT
• evolus launches estyme in europe with commercial debut targeted for may 16 Traders Union Mon, 11 May 2026 13:09:46 GMT
• Evolus to launch Estyme dermal filler line in Europe on May 16 Investing.com Mon, 11 May 2026 07:00:00 GMT
• Evolus to Launch Estyme Dermal Fillers in Europe Orange County Business Journal Mon, 11 May 2026 07:00:00 GMT
• evolus announces commercial launch of estyme® injectable hyaluronic acid gels in europe Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• evolus (eols) to launch estyme injectable collection in europe GuruFocus Mon, 11 May 2026 07:00:00 GMT
• evolus launches estyme® hyaluronic acid gels in select european markets geneonline.com Mon, 11 May 2026 07:00:00 GMT
• evolus may 2026 slides: ha innovation, jeuveau data support dual strategy Investing.com Canada Mon, 11 May 2026 01:17:34 GMT
• Earnings call transcript: Evolus Inc Q1 2026 misses EPS forecast, stock rises Investing.com Nigeria Mon, 11 May 2026 00:23:23 GMT
• Evolus May 2026 slides: HA innovation, Jeuveau data support dual strategy Investing.com Sun, 10 May 2026 07:00:00 GMT
• earnings call transcript: evolus inc q1 2026 misses eps forecast, stock rises Investing.com Sun, 10 May 2026 07:00:00 GMT
• eols evolus revenue climbs 11.6% year-over-year in q2 2026, but shares slip on continued losses. - quarterly financial update newsline.com Sat, 09 May 2026 07:00:00 GMT
• evolus | 4: statement of changes in beneficial ownership of securities-officer moatazedi david Moomoo Fri, 08 May 2026 20:57:33 GMT
• evolus (eols) breakeven q4 eps tests skeptics of its profitability path Sahm Thu, 07 May 2026 16:59:26 GMT
• evolus reiterates 2026 net revenue of $327m-$337m while targeting a low to mid-single-digit adjusted ebitda margin MSN Thu, 07 May 2026 12:09:01 GMT
• Evolus, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:EOLS) 2026-05-07 Seeking Alpha Thu, 07 May 2026 07:00:00 GMT
• evolus (eols) breakeven q4 eps tests skeptics of its profitability path simplywall.st Wed, 06 May 2026 10:00:37 GMT
• analysts are bullish on top healthcare stocks: cg oncology, inc. (cgon), evolus (eols) The Globe and Mail Wed, 06 May 2026 07:00:00 GMT
• evolus faces heightened operational risk from overseas manufacturing and disaster recovery gaps TipRanks Wed, 06 May 2026 06:28:11 GMT
• mizuho securities maintains evolus(eols.us) with buy rating, maintains target price $15 富途牛牛 Wed, 06 May 2026 01:06:44 GMT
• preview-weight-loss revolution sparks new appetite for aesthetics firms Sahm Tue, 05 May 2026 16:02:42 GMT
• evolus reiterates 2026 net revenue of $327m-$337m while targeting a low to mid-single-digit adjusted ebitda margin MSN Tue, 05 May 2026 07:39:29 GMT
• Evolus, Inc. 2026 Q1 Financial Report: Key Risks, Financials, and Business Updates Minichart Tue, 05 May 2026 07:00:00 GMT
• evolus earnings call highlights profitable growth path The Globe and Mail Tue, 05 May 2026 07:00:00 GMT
• evolus, inc. (nasdaq:eols) q1 2026 earnings call transcript Insider Monkey Tue, 05 May 2026 07:00:00 GMT
• a quick look at today's ratings for evolus(eols.us), with a forecast between $13 to $17 Moomoo Tue, 05 May 2026 07:00:00 GMT
• earnings call transcript: evolus misses q1 2026 eps forecast, revenue up Investing.com Australia Tue, 05 May 2026 07:00:00 GMT
• stifel maintains evolus(eols.us) with buy rating, maintains target price $17 Moomoo Tue, 05 May 2026 07:00:00 GMT
• evolus maintains buy rating as scalable growth story solidifies; $13 price target reaffirmed TipRanks Tue, 05 May 2026 07:00:00 GMT
• weight-loss revolution sparks new appetite for aesthetics firms ET HealthWorld Tue, 05 May 2026 02:20:32 GMT
• Is Evolus (EOLS) Finally Turning the Corner on Profitability Kavout | AI Tue, 05 May 2026 01:55:30 GMT
• evolus | 8-k: evolus reports first quarter 2026 financial results; company delivers second consecutive quarter of positive adjuste... Moomoo Tue, 05 May 2026 00:46:39 GMT
• evolus inc (nasdaq:eols) q1 2026 earnings: narrowed loss and positive ebitda drive after-hours rally ChartMill Mon, 04 May 2026 23:21:20 GMT
• eols reports strong q1 revenue and positive adjusted ebitda GuruFocus Mon, 04 May 2026 21:22:30 GMT
• weight-loss revolution sparks new appetite for aesthetics firms Yahoo! Finance Canada Mon, 04 May 2026 15:16:24 GMT
• Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates Yahoo Finance Mon, 04 May 2026 07:00:00 GMT
• Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and R... Business Wire Mon, 04 May 2026 07:00:00 GMT
• Evolus Inc. (EOLS) stock falls on Q1 2026 Earnings Quiver Quantitative Mon, 04 May 2026 07:00:00 GMT
• Evolus Shares up After Q1 Revenue Tops Consensus Orange County Business Journal Mon, 04 May 2026 07:00:00 GMT
• Evolus, Inc. 1Q 2026: Revenue $73.14M, EPS ($0.16) — 10-Q Summary TradingView Mon, 04 May 2026 07:00:00 GMT
• earnings call transcript: evolus misses q1 2026 eps forecast, revenue up Investing.com Mon, 04 May 2026 07:00:00 GMT
• evolus (nasdaq: eols) q1 2026 earnings, guidance and growth outlook Stock Titan Mon, 04 May 2026 07:00:00 GMT
• evolus (nasdaq: eols) grows q1 2026 sales but remains unprofitable Stock Titan Mon, 04 May 2026 07:00:00 GMT
• evolus, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Mon, 04 May 2026 07:00:00 GMT
• evolus, inc. reiterates earnings guidance for the full year 2026 marketscreener.com Mon, 04 May 2026 07:00:00 GMT
• evolus (nasdaq:eols) releases earnings results, misses expectations by $0.02 eps MarketBeat Mon, 04 May 2026 07:00:00 GMT
• evolus | 8-k: evolus reports first quarter 2026 financial results; company delivers second consecutive quarter of positive adjuste... Moomoo Mon, 04 May 2026 07:00:00 GMT
• evolus may 2026 slides: ha innovation, jeuveau data support dual strategy Investing.com Nigeria Mon, 04 May 2026 07:00:00 GMT
• trading the move, not the narrative: (eols) edition Stock Traders Daily Fri, 01 May 2026 20:02:02 GMT
• evolus inc expected to post a loss of 13 cents a share - earnings preview TradingView Fri, 01 May 2026 07:00:00 GMT
• mizuho securities maintains evolus(eols.us) with buy rating, maintains target price $15 Moomoo Thu, 30 Apr 2026 07:00:00 GMT
• evolus (nasdaq: eols) plans 2026 virtual meeting on directors, auditor and executive pay Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
Evolus, Inc(NASDAQ:EOLS) 
Evolus, Inc., a performance beauty company, provides products in the self-pay aesthetic healthcare market for physicians and their patients in the United States. The company offers products for physicians that are sold to consumers or used in procedures for aesthetic indications, which are not reimb...
Website: http://www.evolus.com
Founded: 2012
Full Time Employees: 125
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic